Attached files
file | filename |
---|---|
10-Q - QUARTERLY REPORT - Tanke Biosciences Corp | f10q0612_tanke.htm |
EX-31.2 - Tanke Biosciences Corp | ex31_2.htm |
EX-32.1 - Tanke Biosciences Corp | ex32_1.htm |
EX-31.1 - Tanke Biosciences Corp | ex31_1.htm |
Exhibit 32.2
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the accompanying Quarterly Report on Form 10-Q of Tanke Biosciences Corporation for the period ended June 30, 2012, I, Gilbert Kwong-Yiu Lee, Chief Financial Officer of Tanke Biosciences Corporation, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge and belief, that:
1.
|
Such Quarterly Report on Form 10-Q for the period ended June 30, 2012, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
2.
|
The information contained in such Quarterly Report on Form 10-Q for the period ended June 30, 2012, fairly represents in all material respects, the financial condition and results of operations of Tanke Biosciences Corporation.
|
Dated: August 14, 2012
|
/s/ Gilbert Kwong-Yiu Lee
|
Gilbert Kwong-Yiu Lee
|
|
Chief Financial Officer
(Principal Financial Officer)
|